Victory Capital Management Inc. Decreases Stock Holdings in Humana Inc. $HUM

Victory Capital Management Inc. lowered its position in Humana Inc. (NYSE:HUM) by 77.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 91,460 shares of the insurance provider’s stock after selling 311,480 shares during the period. Victory Capital Management Inc. owned approximately 0.08% of Humana worth $23,795,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of HUM. Illinois Municipal Retirement Fund grew its stake in Humana by 9.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after buying an additional 4,351 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Humana by 161.5% in the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after buying an additional 1,060,767 shares during the last quarter. National Pension Service raised its stake in Humana by 2.8% in the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock valued at $49,328,000 after buying an additional 5,150 shares during the last quarter. Tejara Capital Ltd acquired a new stake in Humana in the third quarter worth about $1,873,000. Finally, AMG National Trust Bank grew its stake in shares of Humana by 106.5% during the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after acquiring an additional 8,744 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Jefferies Financial Group decreased their price objective on shares of Humana from $310.00 to $235.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Barclays cut their price target on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 24th. Wolfe Research lifted their price objective on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. TD Cowen dropped their price objective on shares of Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Finally, Robert W. Baird cut their target price on Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a research report on Thursday, December 11th. Seven investment analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $225.48.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of $185.21 per share, with a total value of $150,020.10. Following the transaction, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $178.25 on Tuesday. Humana Inc. has a twelve month low of $169.61 and a twelve month high of $315.35. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a market cap of $21.50 billion, a PE ratio of 18.15, a price-to-earnings-growth ratio of 1.93 and a beta of 0.44. The company’s 50 day moving average is $220.15 and its 200 day moving average is $251.18.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is presently 36.05%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.